BioCentury
ARTICLE | Clinical News

Seven-day contraceptive patch regulatory update

May 14, 2012 7:00 AM UTC

Agile submitted an NDA to FDA for its AG200-15 once-weekly contraceptive patch. The product is a low-dose transdermal patch containing levonorgestrel and ethinyl estradiol. ...